NDSIB
PFE icon

North Dakota State Investment Board’s Pfizer PFE Stock Holding History

North Dakota State Investment Board’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Sell
168,928
-14,596
-8% -$382K 0.17% 91
2026
Q1 		$5.15M Sell
183,524
-31,255
-15% -$832K 0.22% 65
2025
Q4 		$5.35M Buy
+214,779
New +$5.42M 0.2% 82

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

North Dakota State Investment Board's PFE Position: Q2 2026 in Review

North Dakota State Investment Board reduced its Pfizer (PFE) stake by 8% in Q2 2026, selling an estimated $382K and leaving 168,928 shares worth $4.07M. The position accounts for 0.17% of the portfolio, ranked #91.

North Dakota State Investment Board first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.35M in Q4 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • North Dakota State Investment Board held 168,928 shares of Pfizer worth $4.07M as of Q2 2026.
  • North Dakota State Investment Board sold 14,596 Pfizer shares in Q2 2026, an estimated $382K.
  • Pfizer made up 0.17% of North Dakota State Investment Board's portfolio in Q2 2026, its #91 holding.
  • North Dakota State Investment Board first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Pfizer position peaked at $5.35M in Q4 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.